FineTech Laboratories Overview

  • Founded
  • 1990
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 5

FineTech Laboratories General Information

Description

Developer of active pharmaceutical ingredients created to process and polymorph patents by developing non-infringing processes or polymorphs. The company's active pharmaceutical ingredients include cabergoline, latanoprost, travoprost, nabilone, melatonin and methylbenzethonium chloride, enabling the healthcare sectors to access a wide range of products and services to fulfill their needs and develop their sectors under one roof.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Parent Company
Primary Office
  • 33, Hanarkissim Street
  • Nesher 36608
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

FineTech Laboratories Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore FineTech Laboratories‘s full profile, request access.

Request a free trial

FineTech Laboratories Executive Team (1)

Name Title Board Seat Contact Info
Arie Gutman Ph.D Founder, Chief Executive Officer & President
To view FineTech Laboratories’s complete executive team members history, request access »

FineTech Laboratories Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore FineTech Laboratories‘s full profile, request access.

Request a free trial